Protara Therapeutics, Inc. (NASDAQ: TARA) reported Q3 EPS of ($0.68), $0.29 better than the analyst estimate of ($0.97).

For earnings history and earnings-related data on Protara Therapeutics, Inc. (TARA) click here.